1. Technical Analysis March 2025
Nike’s stock (
NKE ) is currently trading near a 52-week low of $63.19, signaling a bearish trend driven by weak earnings and macroeconomic challenges.
• Moving Averages: The 50-day MA is below the 200-day MA (death cross), confirming a long-term downtrend.
• Relative Strength Index (RSI): Near 30, indicating oversold conditions and a possible short-term rebound.
• Support & Resistance:
• Key support: ~$60 (historical demand zone)
• Key resistance: ~$75–$80 (previous consolidation area)
• Volume Analysis: High selling pressure, but institutional investors may step in at lower levels.
2. Fundamental Analysis March 2025
Nike remains a global leader in the sportswear industry, but recent headwinds have impacted on its financial performance.
Key Financial Metrics (Q3 2025)
• Revenue: $11.3 billion (-9% YoY)
• Net Income: Declining due to lower sales and margin compression
• EPS: Lower than expected, prompting downward revisions by analysts
• Dividend Yield: ~2.3%, with 23 consecutive years of dividend increases
• Debt-to-Equity Ratio: ~0.6, indicating moderate leverage
• Price-to-Earnings (P/E) Ratio: Lower than historical averages (~18–22x), making it relatively undervalued compared to its long-term trends
📈 Strengths:
• Brand Power & Innovation: Nike’s brand remains dominant, and new product lines (e.g., Pegasus Premium, Vomero 18) are receiving positive feedback.
• Global Reach & Direct-to-Consumer (DTC) Shift: Strong e-commerce presence, which could improve margins over time.
• Dividend Growth: 23 consecutive years of increases make Nike attractive to long-term income investors.
📉 Weaknesses & Risks:
• Declining Sales: A 9% revenue drop YoY, with a 17% decline in China—a crucial market.
• Tariff Concerns: New U.S. tariffs on Chinese imports could impact profit margins.
• Competitive Landscape: Adidas, Puma, and newer brands (On Running, Hoka) are gaining market share.
• Macroeconomic Uncertainty: Consumer spending on discretionary goods remains weak.
3. 5-Year Price Prediction (2025–2030)
Year Price Range Prediction
2025 $55 – $85 (high volatility, potential recovery)
2026 $75 – $100 (rebound if sales improve)
2027 $90 – $120 (growth phase, innovation & DTC strategy gains traction)
2028 $110 – $140 (bullish market conditions, brand strength)
2029 $130 – $170 (potential all-time highs if fundamentals align)
2030 $150 – $200 (long-term upside if Nike maintains market dominance)
Conclusion: Buy, Hold, or Sell?
• Short-Term (2025–2026): High risk, potential upside if Nike stabilizes its sales and margins.
• Mid-to-Long Term (2027–2030): Likely strong recovery, given Nike’s brand strength, innovation, and historical growth.
• Best Strategy: Dollar-cost averaging (DCA) for long-term investors; traders may wait for a confirmed reversal.
⚠️ Disclaimer:
This analysis is for informational purposes only and should not be considered financial advice. Stock market investments carry risks, including the loss of capital. Investors should conduct their own research or consult with a financial advisor before making investment decisions.
Nike’s stock (
NKE ) is currently trading near a 52-week low of $63.19, signaling a bearish trend driven by weak earnings and macroeconomic challenges.• Moving Averages: The 50-day MA is below the 200-day MA (death cross), confirming a long-term downtrend.
• Relative Strength Index (RSI): Near 30, indicating oversold conditions and a possible short-term rebound.
• Support & Resistance:
• Key support: ~$60 (historical demand zone)
• Key resistance: ~$75–$80 (previous consolidation area)
• Volume Analysis: High selling pressure, but institutional investors may step in at lower levels.
2. Fundamental Analysis March 2025
Nike remains a global leader in the sportswear industry, but recent headwinds have impacted on its financial performance.
Key Financial Metrics (Q3 2025)
• Revenue: $11.3 billion (-9% YoY)
• Net Income: Declining due to lower sales and margin compression
• EPS: Lower than expected, prompting downward revisions by analysts
• Dividend Yield: ~2.3%, with 23 consecutive years of dividend increases
• Debt-to-Equity Ratio: ~0.6, indicating moderate leverage
• Price-to-Earnings (P/E) Ratio: Lower than historical averages (~18–22x), making it relatively undervalued compared to its long-term trends
📈 Strengths:
• Brand Power & Innovation: Nike’s brand remains dominant, and new product lines (e.g., Pegasus Premium, Vomero 18) are receiving positive feedback.
• Global Reach & Direct-to-Consumer (DTC) Shift: Strong e-commerce presence, which could improve margins over time.
• Dividend Growth: 23 consecutive years of increases make Nike attractive to long-term income investors.
📉 Weaknesses & Risks:
• Declining Sales: A 9% revenue drop YoY, with a 17% decline in China—a crucial market.
• Tariff Concerns: New U.S. tariffs on Chinese imports could impact profit margins.
• Competitive Landscape: Adidas, Puma, and newer brands (On Running, Hoka) are gaining market share.
• Macroeconomic Uncertainty: Consumer spending on discretionary goods remains weak.
3. 5-Year Price Prediction (2025–2030)
Year Price Range Prediction
2025 $55 – $85 (high volatility, potential recovery)
2026 $75 – $100 (rebound if sales improve)
2027 $90 – $120 (growth phase, innovation & DTC strategy gains traction)
2028 $110 – $140 (bullish market conditions, brand strength)
2029 $130 – $170 (potential all-time highs if fundamentals align)
2030 $150 – $200 (long-term upside if Nike maintains market dominance)
Conclusion: Buy, Hold, or Sell?
• Short-Term (2025–2026): High risk, potential upside if Nike stabilizes its sales and margins.
• Mid-to-Long Term (2027–2030): Likely strong recovery, given Nike’s brand strength, innovation, and historical growth.
• Best Strategy: Dollar-cost averaging (DCA) for long-term investors; traders may wait for a confirmed reversal.
⚠️ Disclaimer:
This analysis is for informational purposes only and should not be considered financial advice. Stock market investments carry risks, including the loss of capital. Investors should conduct their own research or consult with a financial advisor before making investment decisions.
MT$
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
MT$
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.